Use of angiotensin-converting enzyme inhibitors in heart failure with preserved left ventricular systolic function
- 1 August 1997
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 134 (2) , 188-195
- https://doi.org/10.1016/s0002-8703(97)70123-6
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Does QI Work? The Management to Improve Survival in Congestive Heart Failure (MISCHF) StudyThe Joint Commission Journal on Quality Improvement, 1996
- Patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure in two community hospitalsThe American Journal of Cardiology, 1996
- Hospitalized congestive heart failure patients with preserved versus abnormal left ventricular systolic function: Clinical characteristics and drug therapyThe American Journal of Medicine, 1995
- Prevalence, clinical features and prognosis of diastolic heart failure: An epidemiologic perspectiveJournal of the American College of Cardiology, 1995
- Quality of life among 5,025 patients with left ventricular dysfunction randomized between placebo and enalapril: The studies of left ventricular dysfunctionJournal of the American College of Cardiology, 1994
- Perspective of the pharmaceutical industry on the development of new drugs for heart failureJournal of the American College of Cardiology, 1993
- Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial InfarctionNew England Journal of Medicine, 1992
- A Comparison of Enalapril with Hydralazine–Isosorbide Dinitrate in the Treatment of Chronic Congestive Heart FailureNew England Journal of Medicine, 1991
- Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart FailureNew England Journal of Medicine, 1991
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987